Biotech, Drugs, Life Sciences Stewart Lyman wrote: Seattle’s biotech community used to be among the top-ranked in the nation. But as some 2,500 layoffs have piled up in the local biotech sector since 2002, Seattle has tumbled in the rankings. We need to face up to this fact first, before we ca...

Biotech, Autoimmune, diabetes Luke Timmerman wrote: Diabetics can’t just quit taking insulin when the economy takes a nosedive. So if you’re the world’s largest producer of insulin for a chronic, and growing, medical condition, your outlook on life isn’t that bad right now. T...

Biotech, Global Health, Life Sciences Luke Timmerman wrote: The global health bug bit Lisa Cohen in 2001. She was a producer at KING5-TV in Seattle at the time, and along with anchorwoman Jean Enerson, she traveled through Africa for two weeks in a delegation with Patty Stonesifer, who was then runn...

Biotech, Drugs, Life Sciences Luke Timmerman wrote: Some of the stories Lynn Rose told me the other week made me laugh out loud, and want to cry in mercy. One story was about the academic researcher who ran a single experiment in an animal species that panned out. This scientist, who shall remain na...

Biotech, vaccines, Xconomy Luke Timmerman wrote: A newfound energy is coalescing around the science and business of vaccines, and much of it is happening right here in Seattle. We explored the trend yesterday evening in our first Xconomy Forum in Seattle. The event, held at The Institute for Systems...

Biotech, philanthropy, Fred Hutchinson Cancer Research Center Luke Timmerman wrote: Get ‘em while they’re young. It’s true of the folks who market breakfast cereals, and also in the world of philanthropy. The Fred Hutchinson Cancer Research Center has a reputation as a world-class ...